JPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN)
AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at JPMorgan Chase & Co. in a research report issued on Wednesday, MarketBeat.com reports. Several other equities research analysts also recently issued reports on the company. Shore Capital reaffirmed a “buy” rating on shares of AstraZeneca in a research report […]
AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at JPMorgan Chase & Co. in a research report issued on Wednesday, MarketBeat.com reports. Several other equities research analysts also recently issued reports on the company. Shore Capital reaffirmed a “buy” rating on shares of AstraZeneca in a research report […]
